EDGAR Filing Documents for 0001093094-09-000006

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001093094-09-000006

Filing Date

2009-02-25

Accepted

2009-02-24 17:33:46

Documents

Period of Report

2008-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-Q FOR PERIOD ENDED DECEMBER 31, 2008	form10q.htm	10-Q	526610
2	AMENDED AND RESTATED ARTICLES OF INCORPORATION	ex3-3.htm	EX-3.3	40362
3	AMENDED AND RESTATED BYLAWS	ex3-4.htm	EX-3.4	183541
4	AMENDED AND RESTATED LONG-TERM INCENTIVE PLAN	ex10-15.htm	EX-10.15	148553
5	EXHIBIT 31.01 - RULE 13A-14 CEO CERTIFICATION	ex31-01.htm	EX-31.01	12366
6	EXHIBIT 31.02 - RULE 13A-14 CFO CERTIFICATION	ex31-02.htm	EX-31.02	13880
7	EXHIBIT 32.01 - CERTIFICATION PURSUANT TO 18 U.S.C.	ex32-01.htm	EX-32.01	12389
8	PRESS RELEASE DATED DECEMBER 11, 2008	ex99-01.htm	EX-99.01	10794
9	PRESS RELEASE DATED DECEMBER 19, 2008	ex99-02.htm	EX-99.02	8344
10	PRESS RELEASE DATED FEBRUARY 9, 2009	ex99-03.htm	EX-99.03	10298
11	COMPANY LOGO	sangui.jpg	GRAPHIC	53364
	Complete submission text file	0001093094-09-000006.txt		1042319

Mailing Address ALFRED-HERRHAUSEN-STRASSE44 WITTEN 2M 58455

Business Address ALFRED-HERRHAUSEN-STRASSE44 WITTEN 2M 58455 011 49 1607 412717

SANGUI BIOTECH INTERNATIONAL INC (Filer) CIK: 0001104280 (see all company filings)